Product Information
HALOPERIDOL LAC 2 MG/ML CONC is a generic product labeled by Advagen Pharma Ltd., priced at $0.1775 per ML under NDC 72888017348. Its NADAC has been published 104 times since Oct 9, 2024.
FDA first approved this application on Jan 31, 2024. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Haloperidol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/mL
Manufacturer
Advagen Pharma Ltd.NDC
72888017348
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOLApproval Type
Generic (ANDA)
FDA Application
ANDA218371FDA Approved
1/31/2024
TE Code
AA
On Market Since
1/31/2024
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL LAC 2 MG/ML CONC has been published 104 times since Oct 9, 2024, and over the history we have for it it has declined 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1775 per ML |
|---|---|
| All-time high | $0.1987 (Sep 10, 2025) |
| All-time low | $0.1775 (Sep 23, 2026) |
| 52-week high | $0.1980 |
| 52-week low | $0.1775 |
| Median price | $0.1908 |
| Average price | $0.1900 |
| Largest weekly change | -3.9% (Sep 23, 2026) |
| Weeks tracked | 104 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL LAC 2 MG/ML CONC?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL LAC 2 MG/ML CONC, manufactured by Advagen Pharma Ltd., is $0.1775 per ML (NDC 72888017348), effective Sep 30, 2026.
How has the price of HALOPERIDOL LAC 2 MG/ML CONC changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL LAC 2 MG/ML CONC has declined 7.0%. It has been tracked across 104 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL LAC 2 MG/ML CONC?
Since Oct 9, 2024, the NADAC for HALOPERIDOL LAC 2 MG/ML CONC has ranged from a low of $0.1775 (Sep 23, 2026) to a high of $0.1987 (Sep 10, 2025), with a median of $0.1908 per ML.
Are there cheaper alternatives to HALOPERIDOL LAC 2 MG/ML CONC?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HALOPERIDOL LAC 2 MG/ML CONC in a comparable dosage form, but none are currently priced below it.
Who manufactures HALOPERIDOL LAC 2 MG/ML CONC?
HALOPERIDOL LAC 2 MG/ML CONC (NDC 72888017348) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.